182 related articles for article (PubMed ID: 26639156)
21. Mitochondrial targeting sequence variants of the CHCHD2 gene are a risk for Lewy body disorders.
Ogaki K; Koga S; Heckman MG; Fiesel FC; Ando M; Labbé C; Lorenzo-Betancor O; Moussaud-Lamodière EL; Soto-Ortolaza AI; Walton RL; Strongosky AJ; Uitti RJ; McCarthy A; Lynch T; Siuda J; Opala G; Rudzinska M; Krygowska-Wajs A; Barcikowska M; Czyzewski K; Puschmann A; Nishioka K; Funayama M; Hattori N; Parisi JE; Petersen RC; Graff-Radford NR; Boeve BF; Springer W; Wszolek ZK; Dickson DW; Ross OA
Neurology; 2015 Dec; 85(23):2016-25. PubMed ID: 26561290
[TBL] [Abstract][Full Text] [Related]
22. Mutational screening of the mitochondrial transcription factors B1 and B2 (TFB1M and TFB2M) in Parkinson's disease.
Sánchez-Ferrero E; Coto E; Blázquez M; Ribacoba R; Guisasola LM; Salvador C; Alvarez V
Parkinsonism Relat Disord; 2009 Jul; 15(6):468-70. PubMed ID: 18980857
[TBL] [Abstract][Full Text] [Related]
23. Mutation analysis of the CHCHD2 gene in Chinese Han patients with Parkinson's disease.
Lu Q; Deng X; Song Z; Guo Y; Yang Y; Deng H
Parkinsonism Relat Disord; 2016 Aug; 29():143-4. PubMed ID: 27118487
[No Abstract] [Full Text] [Related]
24. A novel mutation of CHCHD2 p.R8H in a sporadic case of Parkinson's disease.
Ikeda A; Matsushima T; Daida K; Nakajima S; Conedera S; Li Y; Yoshino H; Oyama G; Funayama M; Nishioka K; Hattori N
Parkinsonism Relat Disord; 2017 Jan; 34():66-68. PubMed ID: 28341223
[No Abstract] [Full Text] [Related]
25. Mutations in CHCHD2 cause α-synuclein aggregation.
Ikeda A; Nishioka K; Meng H; Takanashi M; Hasegawa I; Inoshita T; Shiba-Fukushima K; Li Y; Yoshino H; Mori A; Okuzumi A; Yamaguchi A; Nonaka R; Izawa N; Ishikawa KI; Saiki H; Morita M; Hasegawa M; Hasegawa K; Elahi M; Funayama M; Okano H; Akamatsu W; Imai Y; Hattori N
Hum Mol Genet; 2019 Dec; 28(23):3895-3911. PubMed ID: 31600778
[TBL] [Abstract][Full Text] [Related]
26. Brain glucose metabolism changes in Parkinson's disease patients with CHCHD2 mutation based on (18)F-FDG PET imaging.
Mao CY; Wu P; Zhang SY; Yang J; Liu YT; Zuo CT; Zhuang ZP; Shi CH; Xu YM
J Neurol Sci; 2016 Oct; 369():303-305. PubMed ID: 27653913
[No Abstract] [Full Text] [Related]
27. CHCHD2 accumulates in distressed mitochondria and facilitates oligomerization of CHCHD10.
Huang X; Wu BP; Nguyen D; Liu YT; Marani M; Hench J; Bénit P; Kozjak-Pavlovic V; Rustin P; Frank S; Narendra DP
Hum Mol Genet; 2018 Nov; 27(22):3881-3900. PubMed ID: 30084972
[TBL] [Abstract][Full Text] [Related]
28. The mutation spectrum of Parkinson-disease-related genes in early-onset Parkinson's disease in ethnic Chinese.
Chen YP; Yu SH; Zhang GH; Hou YB; Gu XJ; Ou RW; Shen Y; Song W; Chen XP; Zhao B; Cao B; Zhang LY; Sun MM; Liu FF; Wei QQ; Liu KC; Lin JY; Yang TM; Yang J; Wu Y; Jiang Z; Liu J; Cheng YF; Xiao Y; Su WM; Feng F; Cai YY; Li SR; Hu T; Yuan XQ; Zhou QQ; Shao N; Ma S; Shang HF
Eur J Neurol; 2022 Nov; 29(11):3218-3228. PubMed ID: 35861376
[TBL] [Abstract][Full Text] [Related]
29. Loss of Parkinson's disease-associated protein CHCHD2 affects mitochondrial crista structure and destabilizes cytochrome c.
Meng H; Yamashita C; Shiba-Fukushima K; Inoshita T; Funayama M; Sato S; Hatta T; Natsume T; Umitsu M; Takagi J; Imai Y; Hattori N
Nat Commun; 2017 Jun; 8():15500. PubMed ID: 28589937
[TBL] [Abstract][Full Text] [Related]
30. Translated mutation in the Nurr1 gene as a cause for Parkinson's disease.
Grimes DA; Han F; Panisset M; Racacho L; Xiao F; Zou R; Westaff K; Bulman DE
Mov Disord; 2006 Jul; 21(7):906-9. PubMed ID: 16532445
[TBL] [Abstract][Full Text] [Related]
31. CHCHD2 and CHCHD10-related neurodegeneration: molecular pathogenesis and the path to precision therapy.
Shammas MK; Huang TH; Narendra DP
Biochem Soc Trans; 2023 Apr; 51(2):797-809. PubMed ID: 37021679
[TBL] [Abstract][Full Text] [Related]
32. CHCHD2 p.Thr61Ile knock-in mice exhibit motor defects and neuropathological features of Parkinson's disease.
Fan L; Zhang S; Li X; Hu Z; Yang J; Zhang S; Zheng H; Su Y; Luo H; Liu X; Fan Y; Sun H; Zhang Z; Miao J; Song B; Xia Z; Shi C; Mao C; Xu Y
Brain Pathol; 2023 May; 33(3):e13124. PubMed ID: 36322611
[TBL] [Abstract][Full Text] [Related]
33. Reduced erythrocytic CHCHD2 mRNA is associated with brain pathology of Parkinson's disease.
Liu X; Wang Q; Yang Y; Stewart T; Shi M; Soltys D; Liu G; Thorland E; Cilento EM; Hou Y; Liu Z; Feng T; Zhang J
Acta Neuropathol Commun; 2021 Mar; 9(1):37. PubMed ID: 33685516
[TBL] [Abstract][Full Text] [Related]
34. New Genes Causing Hereditary Parkinson's Disease or Parkinsonism.
Puschmann A
Curr Neurol Neurosci Rep; 2017 Sep; 17(9):66. PubMed ID: 28733970
[TBL] [Abstract][Full Text] [Related]
35. Identification of CHCHD2 mutations in patients with Alzheimer's disease, amyotrophic lateral sclerosis and frontotemporal dementia in China.
Liu X; Jiao B; Zhang W; Xiao T; Hou L; Pan C; Tang B; Shen L
Mol Med Rep; 2018 Jul; 18(1):461-466. PubMed ID: 29749507
[TBL] [Abstract][Full Text] [Related]
36. Involvement of casein kinase 1 epsilon/delta (Csnk1e/d) in the pathogenesis of familial Parkinson's disease caused by CHCHD2.
Torii S; Arakawa S; Sato S; Ishikawa KI; Taniguchi D; Sakurai HT; Honda S; Hiraoka Y; Ono M; Akamatsu W; Hattori N; Shimizu S
EMBO Mol Med; 2023 Sep; 15(9):e17451. PubMed ID: 37578019
[TBL] [Abstract][Full Text] [Related]
37. Pathological characterization of a novel mouse model expressing the PD-linked CHCHD2-T61I mutation.
Kee TR; Wehinger JL; Gonzalez PE; Nguyen E; McGill Percy KC; Khan SA; Chaput D; Wang X; Liu T; Kang DE; Woo JA
Hum Mol Genet; 2022 Nov; 31(23):3987-4005. PubMed ID: 35786718
[TBL] [Abstract][Full Text] [Related]
38. Mitochondrial transcription factor A (TFAM) gene variation in Parkinson's disease.
Alvarez V; Corao AI; Sánchez-Ferrero E; De Mena L; Alonso-Montes C; Huerta C; Blázquez M; Ribacoba R; Guisasola LM; Salvador C; García-Castro M; Coto E
Neurosci Lett; 2008 Feb; 432(1):79-82. PubMed ID: 18248889
[TBL] [Abstract][Full Text] [Related]
39. Genetic screening of Filipinos suspected with familial Parkinson's disease: A pilot study.
Caritativo ECA; Yu JRT; Bautista JMP; Nishioka K; Jamora RDG; Yalung PM; Ng AR; Hattori N
Parkinsonism Relat Disord; 2023 Mar; 108():105319. PubMed ID: 36774704
[TBL] [Abstract][Full Text] [Related]
40. Loss of CHCHD10-CHCHD2 complexes required for respiration underlies the pathogenicity of a CHCHD10 mutation in ALS.
Straub IR; Janer A; Weraarpachai W; Zinman L; Robertson J; Rogaeva E; Shoubridge EA
Hum Mol Genet; 2018 Jan; 27(1):178-189. PubMed ID: 29121267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
